Zobrazeno 1 - 7
of 7
pro vyhledávání: '"De Cecco, Loris"'
Autor:
Rinchai D; Cancer Research Department, Sidra Medicine, Doha, Qatar., Verzoni E; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Huber V; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cova A; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Squarcina P; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Platform of Integrated Biology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., de Braud F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ratta R; Medical Oncology Department, Hopital Foch, Suresnes, France., Dugo M; Platform of Integrated Biology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lalli L; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vallacchi V; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Rodolfo M; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Roelands J; Cancer Research Department, Sidra Medicine, Doha, Qatar., Castelli C; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Chaussabel D; Immunology Research Department, Sidra Medicine, Doha, Qatar., Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bedognetti D; Cancer Research Department, Sidra Medicine, Doha, Qatar.; Dipartimento di Medicina Interna e Specialità Mediche, Università degli Studi di Genova, Genova, Italy.; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar., Rivoltini L; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Clinical and translational medicine [Clin Transl Med] 2021 Jun; Vol. 11 (6), pp. e434.
Autor:
Rybinska, Ilona, Mangano, Nunzia, Romero‐Cordoba, Sandra L., Regondi, Viola, Ciravolo, Valentina, De Cecco, Loris, Maffioli, Elisa, Paolini, Biagio, Bianchi, Francesca, Sfondrini, Lucia, Tedeschi, Gabriella, Agresti, Roberto, Tagliabue, Elda, Triulzi, Tiziana
Publikováno v:
International Journal of Cancer; May2024, Vol. 154 Issue 10, p1842-1856, 15p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
De Cecco, Loris, Serafini, Mara Serena, Facco, Carla, Granata, Roberta, Orlandi, Ester, Fallai, Carlo, Licitra, Lisa, Marchesi, Edoardo, Perrone, Federica, Pilotti, Silvana, Quattrone, Pasquale, Piazza, Cesare, Sessa, Fausto, Turri-Zanoni, Mario, Battaglia, Paolo, Castelnuovo, Paolo, Antognoni, Paolo, Canevari, Silvana, Bossi, Paolo, TURRI ZANONI, Mario
Epithelial sinonasal cancers (SNCs) are rare diseases with overlapping morphological features and a dismal prognosis. We aimed to investigate the expression differences among the histological subtypes for discerning their molecular characteristics. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eb0f0d1267006ea030cb4ce947d4bfd
http://hdl.handle.net/11379/532398
http://hdl.handle.net/11379/532398
Autor:
Rinchai, Darawan, Verzoni, Elena, Huber, Veronica, Cova, Agata, Squarcina, Paola, De Cecco, Loris, Braud, Filippo, Ratta, Raffaele, Dugo, Matteo, Lalli, Luca, Vallacchi, Viviana, Rodolfo, Monica, Roelands, Jessica, Castelli, Chiara, Chaussabel, Damien, Procopio, Giuseppe, Bedognetti, Davide, Rivoltini, Licia
Publikováno v:
Clinical and Translational Medicine
Clinical and Translational Medicine, Vol 11, Iss 6, Pp n/a-n/a (2021)
Clinical and Translational Medicine, Vol 11, Iss 6, Pp n/a-n/a (2021)
Background The combination of immune checkpoint blockade (ICB) with standard therapies is becoming a common approach for overcoming resistance to cancer immunotherapy in most human malignancies including metastatic renal cell carcinoma (mRCC). In thi